Literature DB >> 20146082

Leptomeningeal gliomatosis as the initial presentation of gliomatosis cerebri.

Matthew K Knox1, Cynthia Ménard, Warren P Mason.   

Abstract

Leptomeningeal gliomatosis is a known, yet uncommon, complication of malignant gliomas. In rare instances it can present with non-specific symptoms prior to the development of detectable intraparenchymal lesions, posing a diagnostic challenge. Gliomatosis cerebri is also a rare disease, characterized by extensive diffuse infiltration of neoplastic glial cells. For both entities, limited data exist to guide treatment and prognosis is poor. We describe the case of a patient who presented with symptoms of increased intracranial pressure and diffuse leptomeningeal enhancement in the brain and spinal cord on MRI. After a period of surveillance, intraparenchymal lesions developed in association with widespread diffuse infiltration. The diagnosis of gliomatosis cerebri with diffuse leptomeningeal gliomatosis was established in hindsight. Initial treatment consisted of six cycles of temozolomide chemotherapy. Following radiological progression, the patient received craniospinal radiotherapy. Four months later the patient's symptoms had resolved and MRI demonstrated near complete response of leptomeningeal enhancement and intraparenchymal lesions. Six months after radiotherapy, the patient remains clinically well without radiographic recurrence.

Entities:  

Mesh:

Year:  2010        PMID: 20146082     DOI: 10.1007/s11060-010-0138-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  22 in total

1.  AFIP archives: gliomatosis cerebri affecting the entire neuraxis.

Authors:  Melissa Yip; Christiane Fisch; Jacques B Lamarche
Journal:  Radiographics       Date:  2003 Jan-Feb       Impact factor: 5.333

2.  A case report and review of the literature.

Authors:  Shoji Yomo; Tsuyoshi Tada; Shuichi Hirayama; Naoko Tachibana; Masako Otani; Yuichiro Tanaka; Kazuhiro Hongo
Journal:  J Neurooncol       Date:  2006-09-20       Impact factor: 4.130

3.  Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature.

Authors:  Sophie Taillibert; Catherine Chodkiewicz; Florence Laigle-Donadey; Massimo Napolitano; Stéphanie Cartalat-Carel; Marc Sanson
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

4.  Treatment of meningeal gliomatosis.

Authors:  P F Pradat; K Hoang-Xuan; P Cornu; K Mokhtari; N Martin-Duverneuil; M Poisson; J Y Delattre
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

5.  Combined-modality treatment of leptomeningeal gliomatosis.

Authors:  Marc C Chamberlain
Journal:  Neurosurgery       Date:  2003-02       Impact factor: 4.654

6.  Initial chemotherapy in gliomatosis cerebri.

Authors:  M Sanson; S Cartalat-Carel; S Taillibert; M Napolitano; L Djafari; J Cougnard; H Gervais; F Laigle; A Carpentier; K Mokhtari; L Taillandier; O Chinot; H Duffau; J Honnorat; K Hoang-Xuan; J Y Delattre
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

7.  Clinical outcome in aggressively treated meningeal gliomatosis.

Authors:  R Grant; B Naylor; L Junck; H S Greenberg
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

8.  Diffuse leptomeningeal gliomatosis associated with multifocal CNS infarcts.

Authors:  M Singh; J R Corboy; J C Stears; B K Kleinschmidt-DeMasters
Journal:  Surg Neurol       Date:  1998-10

Review 9.  Gliomatosis cerebri presenting as intractable epilepsy during early childhood.

Authors:  M T Jennings; M Frenchman; T Shehab; M D Johnson; J Creasy; K LaPorte; W D Dettbarn
Journal:  J Child Neurol       Date:  1995-01       Impact factor: 1.987

10.  Cerebral glioblastoma with cerebrospinal fluid dissemination: a clinicopathological study of 14 cases examined by complete autopsy.

Authors:  K Onda; R Tanaka; H Takahashi; N Takeda; F Ikuta
Journal:  Neurosurgery       Date:  1989-10       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.